Clinical Trial Update: Mismatched Donor Cells to Treat Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating mismatched donor cells to treat Acute Myeloid Leukemia. The study status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Mismatched donor cells

Snippet

Sponsor: Maisonneuve-Rosemont Hospital | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: UNKNOWN